These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


138 related items for PubMed ID: 39372827

  • 1. Noonan Syndrome and Celiac Disease in an Adolescent With Short Stature and Delayed Puberty.
    Lee J, Pillai SS, Ganta A, Phornphutkul C, Quintos JB.
    AACE Clin Case Rep; 2024; 10(5):174-178. PubMed ID: 39372827
    [Abstract] [Full Text] [Related]

  • 2. Lack of Catch-Up Growth with Growth Hormone Treatment in a Child Born Small for Gestational Age Leading to a Diagnosis of Noonan Syndrome with a Pathogenic PTPN11 Variant.
    Olivieri DJ, Massingham LJ, Schwab JL, Quintos JB.
    Case Rep Endocrinol; 2021; 2021():5571524. PubMed ID: 34194850
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Final height after combined growth hormone and gonadotrophin-releasing hormone analogue therapy in short healthy children entering into normally timed puberty.
    Lanes R, Gunczler P.
    Clin Endocrinol (Oxf); 1998 Aug; 49(2):197-202. PubMed ID: 9828907
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A Novel Homozygous Mutation of the Acid-Labile Subunit (IGFALS) Gene in a Male Adolescent.
    Poyrazoğlu Ş, Hwa V, Baş F, Dauber A, Rosenfeld R, Darendeliler F.
    J Clin Res Pediatr Endocrinol; 2019 Nov 22; 11(4):432-438. PubMed ID: 30717585
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Growth hormone therapy in patients with Noonan syndrome.
    Seo GH, Yoo HW.
    Ann Pediatr Endocrinol Metab; 2018 Dec 22; 23(4):176-181. PubMed ID: 30599478
    [Abstract] [Full Text] [Related]

  • 9. Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone.
    Pasquino AM, Pucarelli I, Roggini M, Segni M.
    J Clin Endocrinol Metab; 2000 Feb 22; 85(2):619-22. PubMed ID: 10690865
    [Abstract] [Full Text] [Related]

  • 10. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
    Mauras N, Attie KM, Reiter EO, Saenger P, Baptista J.
    J Clin Endocrinol Metab; 2000 Oct 22; 85(10):3653-60. PubMed ID: 11061518
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The effect of celiac disease and gluten-free diet on pubertal development: a two-center study.
    Bayrak NA, Volkan B, Haliloglu B, Kara SS, Cayir A.
    J Pediatr Endocrinol Metab; 2020 Mar 26; 33(3):409-415. PubMed ID: 32069238
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of Growth Characteristics and Final Heights of Cases Diagnosed with Noonan Syndrome on GH Treatment.
    Şıklar Z, Berberoğlu M, Kızılcan Çetin S, Yıldız M, Turan S, Darcan Ş, Çetinkaya S, Hatipoğlu N, Yıldırım R, Demir K, Vermezoğlu Ö, Yavaş Abalı Z, Özalp Kızılay D, Görkem Erdoğan N, Şiraz ÜG, Orbak Z, Özgen İT, Bideci A, Selver Eklioğlu B, Karakılıç Özturan E, Tarçın G, Bereket A, Darendeliler F.
    J Clin Res Pediatr Endocrinol; 2024 Oct 08. PubMed ID: 39377546
    [Abstract] [Full Text] [Related]

  • 14. Growth velocity, final height and bone mineral metabolism of short children treated long term with growth hormone.
    Lanes R.
    Curr Pharm Biotechnol; 2000 Jul 08; 1(1):33-46. PubMed ID: 11467359
    [Abstract] [Full Text] [Related]

  • 15. Improved final height with long-term growth hormone treatment in Noonan syndrome.
    Osio D, Dahlgren J, Wikland KA, Westphal O.
    Acta Paediatr; 2005 Sep 08; 94(9):1232-7. PubMed ID: 16203673
    [Abstract] [Full Text] [Related]

  • 16. Growth hormone is effective in treatment of short stature associated with short stature homeobox-containing gene deficiency: Two-year results of a randomized, controlled, multicenter trial.
    Blum WF, Crowe BJ, Quigley CA, Jung H, Cao D, Ross JL, Braun L, Rappold G, SHOX Study Group.
    J Clin Endocrinol Metab; 2007 Jan 08; 92(1):219-28. PubMed ID: 17047016
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Use of growth hormone and gonadotropin releasing hormone agonist in addition to L-thyroxine to attain normal adult height in two patients with severe Hashimoto's thyroiditis.
    Quintos JB, Salas M.
    J Pediatr Endocrinol Metab; 2005 May 08; 18(5):515-21. PubMed ID: 15921183
    [Abstract] [Full Text] [Related]

  • 20. Long-term GH treatment improves adult height in children with Noonan syndrome with and without mutations in protein tyrosine phosphatase, non-receptor-type 11.
    Noordam C, Peer PG, Francois I, De Schepper J, van den Burgt I, Otten BJ.
    Eur J Endocrinol; 2008 Sep 08; 159(3):203-8. PubMed ID: 18562489
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.